Abstract A100: AXL Inhibitor AB801 Increases the Anti-Tumor Efficacy of KRAS Inhibition
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Jhansi L. Leslie, Logan Chinn, Umida Djakbarova, Ruben Flores, Gonzalo Barajas, Ester Fernandez-Salas, Susan L. Paprcka
Institution: Arcus Biosciences (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415444766
Cites:
Cited by:
Related to:
